NIH Announces Phase III Clinical Trial of Creatine for Parkinson’s Disease – March 22, 2007

Posted by National Institutes of Health (NIH) News Releases on August 1st, 2010 at 05:38am

The NIH National Institute of Neurological Disorders and Stroke (NINDS) today is launching a large-scale clinical trial to learn if the nutritional supplement creatine can slow the progression of Parkinson's disease (PD). While creatine is not an approved therapy for PD or any other condition, it is widely thought to improve exercise performance. The potential benefit of creatine for PD was identified by Parkinson’s researchers through a new rapid method for screening potential compounds.

Under Heart Attack Symptoms